SCHEMBL7575575

SCHEMBL7575575

O=C(O)C(Nc1cc(Cl)ccc1O)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNMA1 Q12791 10/20 0.54
POLB P06746 1/20 0.49
MAPK1 P28482 3/20 0.48
ALOX15 P16050 2/20 0.48
CXCR2 P25025 1/20 0.47
GRIK1 P39086 1/20 0.46
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
TMPRSS4 Q9NRS4 1/20 0.43
MAPT P10636 3/20 0.43
LMNA P02545 2/20 0.43
HPGD P15428 2/20 0.43
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
KDM4E B2RXH2 1/20 0.43
HIF1A Q16665 1/20 0.43
HTT P42858 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7577574 0.86 MEN1 (0.48) KCNMA1POLBMAPK1GRIK1MEN1
SCHEMBL7583928 0.83 TAS1R3 (0.51) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL7577550 0.81 PPARG (0.51) POLBGRIK1MEN1KMT2AMAPT
SCHEMBL7575977 0.80 GAA (0.54) MAPK1MEN1KMT2ALMNAHPGD
SCHEMBL7573328 0.80 ALDH1A1 (0.63) POLBGRIK1MEN1KMT2AMAPT
SCHEMBL7573344 0.77 CXCR2 (0.56) KCNMA1POLBCXCR2MEN1KMT2A
SCHEMBL7574997 0.77 CA2 (0.44) POLBMAPK1MEN1KMT2AMAPT
SCHEMBL7582482 0.76 CA1 (0.46) MEN1KMT2AMAPTKDM4ESMN1; SMN2
SCHEMBL1696047 0.76 MDM2 (0.48) MEN1KMT2AMAPTLMNAHPGD
SCHEMBL6244215 0.76 KCNQ2 (0.53) POLBMAPK1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242069-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2002-09-25 EP disclosed
WO-2001003684-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2001-01-18 WO disclosed